Disclosure: Prof Goldsmith has received funding from Abbvie, Astellas, Bayer, Fresenius Medical Care, Keryx, Relyps, Roche, Sandoz, Sanofi, Shire, Vifor, and ZS Pharma. Prof Mann received honoraria for serving as a speaker from Amgen, Astra, Braun, Fresenius, Gambro, Medice, Novo Nordisk, Relypsa, and Roche; received research funding from the European Union, Canadian Institutes Health Research,...